MedTrace Logo

Neurostimulation Device for Treatment of Migraine Headache

NCT01630044 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2025-03-30

No results posted yet for this study

Summary

This is a single-site, prospective, non-randomized and open label study to investigate the feasibility of home-use CVS for the prevention of episodic migraine headache and specifically to better understand what type of waveform to apply.

Conditions

  • Migraine Headache

Interventions

DEVICE

TNM device

Non-invasive neurostimulator, home-use treatment for up to 43 days.

Sponsors & Collaborators

  • Scion NeuroStim

    lead INDUSTRY

Principal Investigators

  • Daniel Laskowitz, MD · Duke University

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01630044 on ClinicalTrials.gov